Phenotype-dependent and -independent actions of rosuvastatin on atherogenic lipoprotein subfractions in hyperlipidaemia
- 1 December 2003
- journal article
- clinical trial
- Published by Elsevier in Atherosclerosis
- Vol. 171 (2) , 245-253
- https://doi.org/10.1016/j.atherosclerosis.2003.08.025
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Elevated Remnant-Like Particles in Heterozygous Familial Hypercholesterolemia and Response to Statin TherapyCirculation, 2002
- Effect of atorvastatin on low-density lipoprotein subtypes in patients with different forms of hyperlipoproteinemia and control subjectsMetabolism, 2001
- The statin era: in search of the ideal lipid regulating agentHeart, 2001
- Action of Atorvastatin in Combined HyperlipidemiaArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- Comparison of Statins in HypertriglyceridemiaThe American Journal of Cardiology, 1998
- Lipoprotein Heterogeneity and Apolipoprotein B MetabolismArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors and hepatic apolipoprotein B secretionCurrent Opinion in Lipidology, 1997
- Pravastatin Modulates Cholesteryl Ester Transfer From HDL to ApoB-Containing Lipoproteins and Lipoprotein Subspecies Profile in Familial HypercholesterolemiaArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Effects of simvastatin on apoB metabolism and LDL subfraction distribution.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
- Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk.Circulation, 1990